Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Post Market Clinical Study to Compare Vision With Essilor® AVA™ Lenses Following AVA™ Refraction Protocol to Equivalent Lenses Following Gold Standard Refraction Protocol.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07168564
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:13.426656+00:00
Published At
2025-10-03T00:00:00+00:00
Record Updated At
2025-10-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Ametropia", "Refractive Error"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-10-03"
protocolSection.identificationModule.nctId
"NCT07168564"
protocolSection.identificationModule.officialTitle
"Post Market Clinical Study to Compare Vision With Essilor\u00ae AVA\u2122 Lenses Following AVA\u2122 Refraction Protocol to Equivalent Lenses Following Gold Standard Refraction Protocol."
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Ametropia (protocolSection.conditionsModule.conditions)
  • Refractive Error (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.